Breaking News Instant updates and real-time market news.

2020-04-22 12:34:24 AMRN Amarin $6.58 / +0.13 (+2.02%) 12:34 04/22/20 04/22 12:34 04/22/20 12:34	Amarin files for expedited briefing schedule for Vascepa appeal, Markman says Markman Advisors tweeted that Amarin has filed a motion for an expedited briefing schedule for the appeal of the Vascepa patent ruling "with the consent of generics." If granted, Amarin's brief is due by May 12, and oral arguments will likely happen in July or August, according the tweet from the patent advisory firm. Reference Link
AMRN Amarin $6.58 / +0.13 (+2.02%) 04/16/20 Roth Capital Patent lawyer puts high PoS on Amarin appeal, says Roth Capital 04/14/20 Roth Capital Amarin gearing up to push back against ANDA filers ruling, says Roth Capital 04/14/20 Cowen Amarin price target raised to $10 from $8 at Cowen 04/14/20 Stifel Amarin 2020 view 'sufficiently conservative' to still be achievable, says Stifel

2020-04-22 12:34:24

AMRN

Amarin

$6.58 / +0.13 (+2.02%)

12:34

04/22/20

04/22

12:34

04/22/20

12:34

Amarin files for expedited briefing schedule for Vascepa appeal, Markman says

Markman Advisors tweeted that Amarin has filed a motion for an expedited briefing schedule for the appeal of the Vascepa patent ruling "with the consent of generics." If granted, Amarin's brief is due by May 12, and oral arguments will likely happen in July or August, according the tweet from the patent advisory firm. Reference Link

AMRN Amarin

$6.58 / +0.13 (+2.02%)

04/16/20 Roth Capital: Patent lawyer puts high PoS on Amarin appeal, says Roth Capital

04/14/20 Roth Capital: Amarin gearing up to push back against ANDA filers ruling, says Roth Capital

04/14/20 Cowen: Amarin price target raised to $10 from $8 at Cowen

04/14/20 Stifel: Amarin 2020 view 'sufficiently conservative' to still be achievable, says Stifel

TODAY'S FREE FLY STORIES

Recommendations	Altus Group price target raised to C$63 from C$58 at BMO Capital » 12:12 02/25/21 02/25 12:12 02/25/21 12:12 ASGTF Altus Group / + BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research ASGTF Altus Group / + 01/26/21 Invesco Real Estate selects Altus Group as technology partner 01/19/21 Altus Group appoints Alex Probyn as global president, property tax 12/22/20 Altus Group surpasses 1,000 customer milestone for cloud-enabled AE ASGTF Altus Group / + 11:50 Today Scotiabank Altus Group price target raised to C$56 from C$53 at Scotiabank 05:49 Today National Bank Altus Group upgraded to Outperform from Sector Perform at National Bank 01/06/21 CIBC Altus Group price target raised to C$52.50 from C$47.50 at CIBC 11/16/20 Canaccord Altus Group price target raised to C$65 from C$50 at Canaccord
Recommendations	MTBC's efforts to increase organic growth working, says Roth Capital » 12:12 02/25/21 02/25 12:12 02/25/21 12:12 MTBC MTBC $9.67 / -0.39 (-3.88%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MTBC MTBC $9.67 / -0.39 (-3.88%) 11/12/20 MTBC's CareCloud announces partnership with MDS Medical 10/27/20 Barry University School of Podiatric Medicine gose live with MTBC's CareCloud 10/14/20 MTBC's talkEHR announces strategic partnership with AOIA 09/30/20 MTBC's CareCloud selected by Carolina Pediatric Therapy MTBC MTBC $9.67 / -0.39 (-3.88%) 01/28/21 Fly Intel: Top five analyst initiations 01/28/21 Maxim MTBC initiated with a Buy at Maxim 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 07/10/20 Benchmark MTBC initiated with a Buy at Benchmark MTBC MTBC $9.67 / -0.39 (-3.88%) 12/10/20 MTBC lowers FY20 revenue $104M-$106M from $105M-$107M, consensus $106.46M 12/10/20 MTBC sees Q4 results exceeding Q3 results 11/09/20 MTBC reaffirms FY20 revenue view $105M-$107M, consensus $106.33M 11/09/20 MTBC, Inc reports Q3 EPS 27c, consensus (49c) 03/15/21 33rd Annual Roth Virtual Conference 08:30 Today MTBC - MTBC 03/03/21 MTBC
Recommendations	WSP Global price target raised to C$145 from C$140 at Raymond James » 12:10 02/25/21 02/25 12:10 02/25/21 12:10 WSPOF WSP Global $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research WSPOF WSP Global $0.00 / + (+0.00%) 12/03/20 WSP Global to acquire Golder for $1.14B WSPOF WSP Global $0.00 / + (+0.00%) 02/11/21 Scotiabank WSP Global price target raised to C$125 from C$115 at Scotiabank 02/09/21 Desjardins WSP Global price target raised to C$127 from C$117 at Desjardins 02/01/21 Canaccord WSP Global downgraded to Hold from Buy at Canaccord 01/14/21 CIBC WSP Global price target raised to C$145 from C$125 at CIBC
Recommendations	Applied DNA Sciences issued new U.S. patent, says Roth Capital » 12:10 02/25/21 02/25 12:10 02/25/21 12:10 APDN Applied DNA Sciences $9.71 / +0.49 (+5.31%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events APDN Applied DNA Sciences $9.71 / +0.49 (+5.31%) 09:16 Today Applied DNA Sciences gets patent for utilizing DNA tagged submicron particles 02/19/21 Applied DNA to provide back-to-campus COVID surveillance testing to LIM College 01/26/21 Applied DNA Sciences, TruTrace unveil cannabis product validation system 01/20/21 Applied DNA Sciences promotes Judith Murrah to the role of COO APDN Applied DNA Sciences $9.71 / +0.49 (+5.31%) 02/19/21 Roth Capital Roth Capital looks forward to Applied DNA's safeCircle driving NT revenue 02/12/21 Roth Capital Applied DNA Sciences initiated with a Buy at Roth Capital 01/14/21 H.C. Wainwright Applied DNA Sciences price target lowered to $14 from $18 at H.C. Wainwright 01/11/21 H.C. Wainwright Applied DNA Sciences price target raised to $18 from $12 at H.C. Wainwright APDN Applied DNA Sciences $9.71 / +0.49 (+5.31%) 01/04/21 Applied DNA Sciences sees Q1 revenue $1.3M-$1.6M, two estimates $1.05M 03/15/21 33rd Annual Roth Virtual Conference
Recommendations	Enerflex price target raised to C$9.50 from C$8.50 at Raymond James » 12:09 02/25/21 02/25 12:09 02/25/21 12:09 ENRFF Enerflex $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ENRFF Enerflex $0.00 / + (+0.00%) 01/19/21 CIBC Enerflex initiated with a Neutral at CIBC 01/15/21 National Bank Enerflex price target raised to C$10 from C$8 at National Bank 08/10/20 BMO Capital Enerflex price target lowered to C$7 from C$9 at BMO Capital 08/07/20 Raymond James Enerflex price target lowered to C$9 from C$10.25 at Raymond James

Recommendations	Centerra Gold price target lowered to C$18.50 from C$19.50 at Raymond James » 12:09 02/25/21 02/25 12:09 02/25/21 12:09 CAGDF Centerra Gold $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CAGDF Centerra Gold $0.00 / + (+0.00%) 10/06/20 Centerra Gold confirms continuation of operations at Kumtor Mine CAGDF Centerra Gold $0.00 / + (+0.00%) 11:53 Today Scotiabank Centerra Gold price target raised to C$22 from C$20 at Scotiabank 11:26 Today TD Securities Centerra Gold price target raised to C$17 from C$16.50 at TD Securities 10:53 Today National Bank Centerra Gold price target lowered to C$20 from C$21.50 at National Bank 02/08/21 CIBC Centerra Gold downgraded to Neutral from Outperformer at CIBC
Recommendations	Canfor Pulp price target raised to C$13.50 from C$9.50 at Raymond James » 12:08 02/25/21 02/25 12:08 02/25/21 12:08 CFPUF Canfor Pulp $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CFPUF Canfor Pulp $0.00 / + (+0.00%) 11:53 Today Scotiabank Canfor Pulp price target raised to C$7 from C$6.50 at Scotiabank 02/09/21 Scotiabank Canfor Pulp price target raised to C$6.50 from C$6 at Scotiabank 12/18/20 CIBC Canfor Pulp price target raised to C$8.50 from C$5.50 at CIBC 12/10/20 Raymond James Canfor Pulp price target raised to C$9.50 from C$8 at Raymond James
Recommendations	Canfor price target raised to C$40 from C$37.50 at Raymond James » 12:08 02/25/21 02/25 12:08 02/25/21 12:08 CFPZF Canfor $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CFPZF Canfor $0.00 / + (+0.00%) 11:53 Today Scotiabank Canfor price target raised to C$29 from C$27 at Scotiabank 02/04/21 Canfor price target raised to C$34 from C$29 at CIBC 01/13/21 Raymond James Canfor price target raised to C$37.50 from C$35 at Raymond James 01/06/21 Scotiabank Canfor price target raised to C$27 from C$24 at Scotiabank
Recommendations	Piper Sandler 'impressed' with Madrigal progress in enrolling MAESTRO-NASH » 12:08 02/25/21 02/25 12:08 02/25/21 12:08 MDGL Madrigal Pharmaceuticals $126.41 / +3.45 (+2.81%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events MDGL Madrigal Pharmaceuticals $126.41 / +3.45 (+2.81%) 11/13/20 Madrigal discloses data from MAESTRO-NAFLD trial ahead of AASLD presentation 10/01/20 Madrigal announces acceptance of three abstracts for The Liver Meeting 09/03/20 Madrigal exceeds target enrollment in Phase 3 MAESTRO NAFLD-1 trial MDGL Madrigal Pharmaceuticals $126.41 / +3.45 (+2.81%) 11/23/20 Evercore ISI Madrigal Pharmaceuticals resumed with an Outperform at Evercore ISI 11/06/20 Goldman Sachs Madrigal Pharmaceuticals price target raised to $126 from $118 at Goldman Sachs 11/06/20 Piper Sandler Piper sees 'ideal time to buy' Madrigal Pharmaceuticals ahead of AASLD meeting 11/06/20 H.C. Wainwright Madrigal Pharmaceuticals price target raised to $184 from $165 at H.C. Wainwright MDGL Madrigal Pharmaceuticals $126.41 / +3.45 (+2.81%) 07:00 Today Madrigal Pharmaceuticals reports Q3 EPS ($3.82), consensus ($3.85). 11/05/20 Madrigal Pharmaceuticals reports Q3 EPS ($3.75), consensus ($3.30) MDGL Madrigal Pharmaceuticals $126.41 / +3.45 (+2.81%) 11/12/20 Before the Move: Watch Madrigal Pharmaceuticals ahead of AASLD meeting 00:00 Today 10th Annual Global Healthcare Virtual Conference
Recommendations	Baytex Energy price target raised to C$1.25 from C$1 at Raymond James » 12:07 02/25/21 02/25 12:07 02/25/21 12:07 BTEGF Baytex Energy $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events BTEGF Baytex Energy $0.00 / + (+0.00%) 11:25 Today TD Securities Baytex Energy price target raised to C$1.30 from C$0.90 at TD Securities 10:51 Today National Bank Baytex Energy price target raised to C$1.75 from C$1.50 at National Bank 02/19/21 National Bank Baytex Energy price target raised to C$1.50 from C$1.00 at National Bank 01/14/21 Scotiabank Baytex Energy price target raised to C$1 from C$0.70 at Scotiabank 11:00 Today Baytex Energy - BTEGF

General news	8-Week Bill Auction Total Amount data reported » 12:07 02/25/21 02/25 12:07 02/25/21 12:07 8-Week Bill Auction Total… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
General news	4-Week Bill Auction Total Amount data reported » 12:07 02/25/21 02/25 12:07 02/25/21 12:07 4-Week Bill Auction Total… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Royal Bank of Canada price target raised to C$115 from C$109 at Credit Suisse » 12:06 02/25/21 02/25 12:06 02/25/21 12:06 RY Royal Bank of Canada $88.55 / -0.84 (-0.94%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RY Royal Bank of Canada $88.55 / -0.84 (-0.94%) 02/24/21 Royal Bank of Canada reports Q1 ROE of 18.6%, up 100 bps y/y 01/28/21 Alliance Data: Bread announces technology partnership with Royal Bank of Canada 12/04/20 RBC now accepting applications for Canada's expanded CEBA loan program 12/02/20 Royal Bank of Canada reports Q4 CET1 ratio 12.5%, up 40 bps vs. last year RY Royal Bank of Canada $88.55 / -0.84 (-0.94%) 11:58 Today Scotiabank Royal Bank of Canada price target raised to C$133 from C$129 at Scotiabank 11:28 Today TD Securities Royal Bank of Canada price target raised to C$125 from C$120 at TD Securities 11:24 Today National Bank Royal Bank of Canada price target raised to C$123 from C$117 at National Bank 08:45 Today Canaccord Royal Bank of Canada price target raised to C$123 from C$16 at Canaccord RY Royal Bank of Canada $88.55 / -0.84 (-0.94%) 02/24/21 Royal Bank of Canada reports Q1 diluted EPS C$2.66, up 11% y/y 12/02/20 Royal Bank of Canada reports Q4 diluted EPS C$2.23 vs. C$2.18 a year ago 08/26/20 Royal Bank of Canada reports Q3 diluted EPS C$2.20, down 1% y/y
Options	T Mobile call volume above normal and directionally bullish » 12:05 02/25/21 02/25 12:05 02/25/21 12:05 TMUS T-Mobile $120.91 / +1.57 (+1.32%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TMUS T-Mobile $120.91 / +1.57 (+1.32%) 02/17/21 T-Mobile, Curiosity Lab and GIT collaborate on 5G incubator program 02/16/21 Appaloosa buys Macy's and Kohl's, exits AT&T in Q4 02/16/21 Berkshire Hathaway buys Verizon, exits Barrick Gold in Q4 02/04/21 T-Mobile sees FY21 postpaid net adds 4M-4.7M TMUS T-Mobile $120.91 / +1.57 (+1.32%) 08:48 Today Scotiabank Verizon downgraded to Sector Perform from Outperform at Scotiabank 07:07 Today Oppenheimer Verizon, AT&T downgraded to Perform on valuation at Oppenheimer 02/05/21 RBC Capital T-Mobile price target raised to $133 from $120 at RBC Capital 02/05/21 Truist T-Mobile price target raised to $150 from $135 at Truist TMUS T-Mobile $120.91 / +1.57 (+1.32%) 02/04/21 T-Mobile reports Q4 EPS 60c, consensus 51c 02/04/21 Notable companies reporting after market close 11/05/20 T-Mobile raises H2 postpaid net additions view to 1.3M-1.4M from 600k-700k 11/05/20 T-Mobile reports Q3 EPS $1.00, consensus 43c 24 Jun TMUS T-Mobile $120.91 / +1.57 (+1.32%) 06:14 Today Verizon tops 5G spectrum bidders with $45.5B pledge in FCC auction, WSJ reports 10/22/20 T-Mobile expected to announce streaming TV service next week, The Desk says 10/17/20 Apple September quarter could be messy, Barron's says 09/23/20 T-Mobile's 5G ascent rattles both AT&T and Verizon, Fierce Wireless says TMUS T-Mobile $120.91 / +1.57 (+1.32%) 11:04 Today Analysts cut Verizon, AT&T ratings after companies spend big in FCC auction 10:03 Today Lowe's, Square upgrades among today's top calls on Wall Street 02/04/21 Fly Intel: After-Hours Movers 12/22/20 T-Mobile upgrade, Hyatt downgrade among today's top calls on Wall Street 03/11/21 T-Mobile US, Inc. TMUS T-Mobile $120.91 / +1.57 (+1.32%) 10/28/20 T Mobile put volume heavy and directionally bearish 10/14/20 T Mobile call volume above normal and directionally bullish 10/06/20 T Mobile put volume heavy and directionally bearish 09/30/20 T Mobile put volume heavy and directionally bearish
Periodicals	DiaSorin considering acquisition of Luminex, Bloomberg reports » 12:04 02/25/21 02/25 12:04 02/25/21 12:04 LMNX Luminex $32.15 / +2 (+6.63%) , DSRLF DiaSorin SpA $0.00 / + (+0.00%) DiaSorin (DSRLF) is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly LMNX DSRLF LMNX Luminex $32.15 / +2 (+6.63%) 10:35 Today Luminex trading resumes 10:34 Today Luminex jumps 17% to $35.07 after Bloomberg says DiaSorin weighing buyout 10:30 Today Luminex trading halted, volatility trading pause 02/19/21 Luminex receives $11.3M in BARDA funding for Aries assay DSRLF DiaSorin SpA $0.00 / + (+0.00%) 09/08/20 DiaSorin, MeMed partner to develop, commercialize diagnostics solution LMNX DSRLF LMNX Luminex $32.15 / +2 (+6.63%) 02/18/21 Piper Sandler Luminex shares are undervalued, says Piper Sandler 12/17/20 BTIG Illumina upgraded to Buy from Neutral at BTIG 11/09/20 Piper Sandler Buy companies with COVID-19 tests on today's selloff, says Piper Sandler 11/06/20 Piper Sandler Luminex's new product launches can drive long-term growth, says Piper Sandler DSRLF DiaSorin SpA $0.00 / + (+0.00%) 12/10/20 Exane BNP Paribas DiaSorin SpA price target raised to EUR 145 from EUR 135 at Exane BNP Paribas 12/10/20 Kepler Cheuvreux DiaSorin SpA upgraded to Buy from Hold at Kepler Cheuvreux 12/10/20 Kepler Cheuvreux DiaSorin SpA upgraded to Buy from Hold at Kepler Cheuvreux 12/09/20 Morgan Stanley DiaSorin SpA initiated with an Equal Weight at Morgan Stanley LMNX LMNX Luminex $32.15 / +2 (+6.63%) 02/08/21 Luminex backs 2021 revenue view $480M, consensus $474.36M 02/08/21 Luminex reports Q4 EPS 32c, consensus 13c 01/12/21 Luminex sees FY21 revenue $480M, consensus $474.36M 01/12/21 Luminex reports preliminary Q4 revenue $111M, consensus $104.57M LMNX DSRLF LMNX Luminex $32.15 / +2 (+6.63%) 10:36 Today Luminex jumps after Bloomberg says DiaSorin exploring takeover 10:33 Today Italy's DiaSorin considering acquisition of Luminex, Bloomberg reports 09/09/20 Report says U.S. may need 193M coronavirus tests per month, STAT reports DSRLF DiaSorin SpA $0.00 / + (+0.00%) 10:36 Today Luminex jumps after Bloomberg says DiaSorin exploring takeover LMNX LMNX Luminex $32.15 / +2 (+6.63%) 02/08/21 Fly Intel: After-Hours Movers 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 11/05/20 Fly Intel: After-Hours Movers 10/07/20 Fly Intel: Wall Street's top stories for Wednesday

Recommendations	Bank of Nova Scotia price target raised to C$79 from C$72 at Desjardins » 12:03 02/25/21 02/25 12:03 02/25/21 12:03 BNS Bank of Nova Scotia $60.19 / -1.015 (-1.66%) Desjardins analyst Doug… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings BNS Bank of Nova Scotia $60.19 / -1.015 (-1.66%) 02/24/21 Canaccord Bank of Nova Scotia price target raised to C$77 from C$70.50 at Canaccord 02/24/21 BMO Capital Bank of Nova Scotia price target raised to C$80 from C$75 at BMO Capital 02/24/21 National Bank Bank of Nova Scotia price target raised to C$77 from C$70 at National Bank 02/24/21 RBC Capital Bank of Nova Scotia price target raised to C$84 from C$77 at RBC Capital BNS Bank of Nova Scotia $60.19 / -1.015 (-1.66%) 08/26/20 Bank of Nova Scotia reports Q3 adjusted EPS C$1.04 vs. C$1.50 a year ago
Hot Stocks	Goodyear Tire names CTO Chris Helsel as SVP, Global Operations » 12:03 02/25/21 02/25 12:03 02/25/21 12:03 GT Goodyear Tire $16.77 / -0.14 (-0.83%) Goodyear Tire &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options GT Goodyear Tire $16.77 / -0.14 (-0.83%) 02/22/21 Goodyear Tire to acquire Cooper Tire in deal with enterprise value of $2.5B 02/22/21 Goodyear Tire to acquire Cooper Tire in deal with enterprise value of $2.5B 02/09/21 Goodyear Tire CEO says 'we have good momentum as we enter 2021' 02/09/21 Goodyear Tire reports Q4 tire unit volumes 37.7M, down 5% y/y GT Goodyear Tire $16.77 / -0.14 (-0.83%) 02/16/21 Argus Goodyear Tire upgraded to Buy from Hold at Argus 02/16/21 Argus Goodyear Tire upgraded to Buy from Hold at Argus 02/10/21 Northcoast Goodyear Tire price target raised to $15 from $12 at Northcoast 02/10/21 Fly Intel: Top five analyst upgrades GT Goodyear Tire $16.77 / -0.14 (-0.83%) 02/09/21 Goodyear Tire reports Q4 adjusted EPS 44c, consensus 16c 10/30/20 Goodyear Tire reports Q3 adjustes EPS 10c, consensus (6c) 10/29/20 Notable companies reporting before tomorrow's open 10/29/20 Notable companies reporting before tomorrow's open GT Goodyear Tire $16.77 / -0.14 (-0.83%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Pre-market Movers 01/08/21 Another Tesla upgrade among today's top calls on Wall Street GT Goodyear Tire $16.77 / -0.14 (-0.83%) 01/08/21 Early notable gainers among liquid option names on January 8th 12/31/20 Goodyear Tire call volume above normal and directionally bullish 12/31/20 Early notable gainers among liquid option names on December 31st 11/03/20 Early notable gainers among liquid option names on November 3rd
Recommendations	Bank of Montreal price target raised to C$111 from C$100 at Desjardins » 12:02 02/25/21 02/25 12:02 02/25/21 12:02 BMO Bank of Montreal $85.04 / -1.25 (-1.45%) Desjardins analyst Doug… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals BMO Bank of Montreal $85.04 / -1.25 (-1.45%) 10/02/20 Bank of Montreal announces 1-for-20 reverse split of NRGU ETNs BMO Bank of Montreal $85.04 / -1.25 (-1.45%) 02/24/21 Canaccord Bank of Montreal price target raised to C$112.50 from C$106.50 at Canaccord 02/24/21 National Bank Bank of Montreal price target raised to C$113 from C$102 at National Bank 02/24/21 RBC Capital Bank of Montreal price target raised to C$125 from C$110 at RBC Capital 02/24/21 Scotiabank Bank of Montreal price target raised to C$126 from C$111 at Scotiabank BMO Bank of Montreal $85.04 / -1.25 (-1.45%) 02/23/21 Bank of Montreal reports Q1 adjusted EPS C$3.06 vs. C$2.41 last year 12/01/20 Bank of Montreal reports Q4 adj. EPS C$2.41 vs. C$2.43 last year BMO Bank of Montreal $85.04 / -1.25 (-1.45%) 02/03/21 USA Rare Earth exploring New York listing, WSJ reports
Recommendations	Whitecap Resources price target raised to C$7.50 from C$7 at RBC Capital » 12:02 02/25/21 02/25 12:02 02/25/21 12:02 SPGYF Whitecap Resources $0.00 / + (+0.00%) RBC Capital analyst Luke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SPGYF Whitecap Resources $0.00 / + (+0.00%) 10:55 Today National Bank Whitecap Resources price target raised to C$8 from C$4.75 at National Bank 02/23/21 RBC Capital Whitecap Resources price target raised to C$7 from C$6.50 at RBC Capital 01/20/21 Scotiabank Whitecap Resources price target raised to C$6 from C$2.50 at Scotiabank 01/15/21 RBC Capital Whitecap Resources price target raised to C$6.50 from C$3.50 at RBC Capital
Hot Stocks	Metromile names Junna Ro as general counsel » 12:02 02/25/21 02/25 12:02 02/25/21 12:02 MILE Metromile $15.77 / -1.24 (-7.29%) Metromile announced Junna… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Options MILE Metromile $15.77 / -1.24 (-7.29%) 02/10/21 Metromile appoints Betsy Cohen to board of directors 02/09/21 Metromile completes business combination with INSU Acquisition MILE Metromile $15.77 / -1.24 (-7.29%) 02/10/21 Seven new option listings and three option delistings on February 10th

Recommendations	Trican Well Service price target raised to C$2.50 from C$2 at RBC Capital » 12:01 02/25/21 02/25 12:01 02/25/21 12:01 TOLWF Trican Well Service $0.00 / + (+0.00%) RBC Capital analyst Keith… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TOLWF Trican Well Service $0.00 / + (+0.00%) 02/24/21 Raymond James Trican Well Service price target raised to C$2.50 from C$2.30 at Raymond James 02/24/21 TD Securities Trican Well Service price target raised to C$2 from C$1.90 at TD Securities 01/12/21 Raymond James Trican Well Service upgraded to Strong Buy from Market Perform at Raymond James 01/11/21 BMO Capital Trican Well Service upgraded to Outperform from Market Perform at BMO Capital
Hot Stocks	Chubb board to recommend 28th consecutive annual dividend increase » 12:01 02/25/21 02/25 12:01 02/25/21 12:01 CB Chubb $166.74 / -4.09 (-2.39%) Chubb Limited announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options CB Chubb $166.74 / -4.09 (-2.39%) 02/03/21 Chubb raises share repurchase program by $1B 02/02/21 Chubb CEO says 'excellent fourth quarter finish to the year' 01/15/21 Chubb CFO Philip Bancroft to retire, Peter Enns to succeed 01/12/21 Chubb names Jeremiah Konz as Chief Reinsurance Officer CB Chubb $166.74 / -4.09 (-2.39%) 02/04/21 Chubb price target raised to $175 from $155 at RBC Capital 02/04/21 Barclays Chubb price target raised to $178 from $173 at Barclays 01/08/21 Goldman Sachs Chubb upgraded to Conviction Buy from Buy at Goldman Sachs 01/04/21 JPMorgan Chubb downgraded to Neutral after share recovery at JPMorgan CB Chubb $166.74 / -4.09 (-2.39%) 02/02/21 Chubb reports Q4 core EPS $3.18, consensus $2.82 10/27/20 Chubb reports Q3 core EPS $2.00, consensus $2.29 CB Chubb $166.74 / -4.09 (-2.39%) 02/02/21 Fly Intel: After-Hours Movers 12/22/20 T-Mobile upgrade, Hyatt downgrade among today's top calls on Wall Street 10/27/20 Fly Intel: After-Hours Movers CB Chubb $166.74 / -4.09 (-2.39%) 10/28/20 Early notable gainers among liquid option names on October 28th
Hot Stocks	Warrior Met Coal falls -17.8% » 12:00 02/25/21 02/25 12:00 02/25/21 12:00 HCC Warrior Met Coal $21.08 / -4.515 (-17.64%) Warrior Met Coal is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly HCC Warrior Met Coal $21.08 / -4.515 (-17.64%) 10:01 Today Warrior Met Coal falls -13.6% 02/24/21 Warrior Met Coal not providing FY21 guidance 10/28/20 Warrior Met Coal further delays development of Blue Creek project 10/09/20 Warrior Met Coal falls -7.4% HCC Warrior Met Coal $21.08 / -4.515 (-17.64%) 08:52 Today B. Riley Securities Warrior Met Coal price target raised to $28 from $25 at B. Riley Securities 01/13/21 Deutsche Bank Warrior Met Coal downgraded to Hold from Buy at Deutsche Bank 01/13/21 Deutsche Bank Warrior Met Coal downgraded to Hold from Buy at Deutsche Bank 12/17/20 BMO Capital Warrior Met Coal downgraded to Market Perform from Outperform at BMO Capital HCC Warrior Met Coal $21.08 / -4.515 (-17.64%) 02/24/21 Warrior Met Coal reports Q4 EPS (63c), consensus (33c) 10/28/20 Warrior Met Coal reports Q3 EPS (28c), consensus (28c) HCC Warrior Met Coal $21.08 / -4.515 (-17.64%) 02/24/21 Fly Intel: After-Hours Movers
Hot Stocks	U.S. Physical Therapy falls -21.5% » 12:00 02/25/21 02/25 12:00 02/25/21 12:00 USPH U.S. Physical Therapy $111.71 / -30.295 (-21.33%) U.S. Physical Therapy is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events USPH U.S. Physical Therapy $111.71 / -30.295 (-21.33%) 10:00 Today U.S. Physical Therapy falls -16.8% 10/01/20 U.S. Physical Therapy announces its second acquisition of 2020 09/22/20 U.S. Physical Therapy announces Larry McAfee will retire as CFO USPH U.S. Physical Therapy $111.71 / -30.295 (-21.33%) 10/28/20 Barrington Varian Medical downgraded to Underperform from Outperform at Barrington 08/07/20 Barrington U.S. Physical Therapy price target raised to $100 from $95 at Barrington 06/08/20 Barrington U.S. Physical Therapy price target raised to $95 from $84 at Barrington 04/30/20 Sidoti U.S. Physical Therapy downgraded to Neutral following run-up at Sidoti USPH U.S. Physical Therapy $111.71 / -30.295 (-21.33%) 08:41 Today U.S. Physical Therapy reports Q4 EPS 68c, consensus 83c 08:41 Today U.S. Physical Therapy reports Q4 EPS 68c, consensus 83c 11/05/20 U.S. Physical Therapy reports Q3 EPS 61c, consensus 51c 10:30 Today U.S. Physical Therapy - USPH
Hot Stocks	Ping Identity falls -22.6% » 12:00 02/25/21 02/25 12:00 02/25/21 12:00 PING Ping Identity $25.10 / -7.42 (-22.82%) Ping Identity is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly PING Ping Identity $25.10 / -7.42 (-22.82%) 10:00 Today Ping Identity falls -18.3% 09:47 Today Ping Identity falls -18.3% 11/05/20 Ping Identity falls -15.9% 11/05/20 Ping Identity falls -15.0% PING Ping Identity $25.10 / -7.42 (-22.82%) 08:48 Today Wells Fargo Ping Identity price target raised to $40 from $35 at Wells Fargo 07:09 Today Deutsche Bank Ping Identity price target lowered to $25.50 from $32 at Deutsche Bank 06:50 Today Mizuho Ping Identity price target lowered to $30 from $32 at Mizuho 06:05 Today Credit Suisse Ping Identity downgraded to Neutral from Outperform at Credit Suisse PING Ping Identity $25.10 / -7.42 (-22.82%) 02/24/21 Ping Identity sees FY21 revenue $255M-$265M, consensus $291.38M 02/24/21 Ping Identity sees Q1 revenue $61.5M-$63.5M, consensus $67.41M 02/24/21 Ping Identity reports Q4 EPS (4c), consensus 9c 11/04/20 Ping Identity sees Q4 revenue $67M-$70M, consensus $68.75M 15 Dec 09 Jul 14 May PING Ping Identity $25.10 / -7.42 (-22.82%) 02/24/21 Fly Intel: After-Hours Movers 12/21/20 Analysts move to sidelines on SolarWinds following cyberattack 11/04/20 Fly Intel: After-Hours Movers

Events

Earnings calls, analyst events, roadshows and more

OMP
Today at 12:30

Oasis Midstream Partners - OMP Conference Calls
Today at 13:00

7-Year Note Auction Government Event
VRS
Today at 13:00

Verso - VRS Conference Calls
FVE
Today at 13:00

Five Star Senior Living - FVE Conference Calls
ARAY
Today at 13:00

Accuray - ARAY Conference Calls
BNL
Today at 13:00

Broadstone Net Lease - BNL Conference Calls
KALU
Today at 13:00

Kaiser Aluminum - KALU Conference Calls
IIPR
Today at 13:00

Innovative Industrial Properties - IIPR Conference Calls
TGP
Today at 13:00

Teekay LNG - TGP Conference Calls
TCPC
Today at 13:00

BlackRock TCP Capital - TCPC Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	OUT X OUT Outfront Media Block Trade Managers: Morgan Stanley Priced at: $22.00 1.76M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BWAY X BWAY Brainsway Spot Secondary Managers: Oppenheimer Priced at: $8.50 4.62M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CCL X CCL Carnival Spot Secondary Managers: Goldman Sachs Priced at: $25.10 40.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAVM X PAVM PAVmed Spot Secondary Managers: Cantor Fitzgerald Priced at: $4.60 9.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SHOP X SHOP Shopify Spot Secondary Managers: Citi, Credit Suisse & Goldman Sachs Priced at: $1,315 1.18M Shares
Tues	DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $42.70 11M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BCTX X BCTX BriaCell IPO Managers: ThinkEquity Priced at: $4.25 5.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BFRA X BFRA Biofrontera Secondary Managers: Benchmark, LAKE Priced at: $6.68 1.334M Shares FRPT X FRPT Freshpet Secondary Managers: BofA, Baird & Truist Priced at: $143.00 2.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CELC X CELC Celcuity Spot Secondary Managers: Craig-Hallum Priced at: $14.00 1.714M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	SCR X SCR Score Media Secondary Managers: Morgan Stanley, Credit Suisse, Canaccord & Macquarie Priced at: $27.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TROX X TROX Tronox Secondary Managers: JPMorgan, BofA, Deutsche Bank, Morgan Stanley Priced at: $18.25 19.11M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ADMS X ADMS Adamas Pharmaceuticals Spot Secondary Managers: SVB Leerink, William Blair & JMP Securities Priced at: $4.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APEI X APEI American Public Education Spot Secondary Managers: Truist & William Blair Priced at: $25.00 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GPRE X GPRE Green Plains Spot Secondary Managers: Jefferies & BofA Priced at: $23.00 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IFRX X IFRX InflaRx Spot Secondary Managers: Guggenheim & Raymond James Priced at: $5.00 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ITP X ITP IT Tech Packaging Spot Secondary Managers: Maxim Priced at: $.75 26.667M Shares RCEL X RCEL Avita Medical Spot Secondary Managers: Piper Sandler & Cowen Priced at: $21.50 2.795M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	APAM X APAM Artisan Partners Spot Secondary Managers: BofA $49.38 1.11M Shares
Thurs	GTES X GTES Gates Industrial Secondary Managers: Citi & Evercore ISI, Barclays, Credit Suisse, Goldman Sachs, Morgan Stanley, RBC Capital, UBS, Baird, Nomura, Wells Fargo, Guggenheim, KeyBanc $17.87 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Amarin files for expedited briefing schedule for Vascepa appeal, Markman says

TODAY'S FREE FLY STORIES

Get Full Fly Access